Report

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 33
1.4 MARKET STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.2 RESEARCH DESIGN 36
2.2.1 SECONDARY RESEARCH 37
2.2.1.1 Key data from secondary sources 38
2.2.2 PRIMARY RESEARCH 39
2.2.2.1 Key industry insights 40
2.3 MARKET SIZE ESTIMATION METHODOLOGY 41
2.3.1 BOTTOM-UP APPROACH 42
2.3.1.1 Approach 1: Company revenue estimation approach 43
2.3.1.2 Approach 2: Customer-based market estimation 44
2.3.1.3 Approach 3: Top-down approach 45
2.3.1.4 Approach 4: Primary interviews 45
2.3.1.5 Growth forecast 45
2.3.1.6 CAGR projection 46
2.3.2 TOP-DOWN APPROACH 46
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 47
2.5 MARKET SHARE ASSESSMENT 48
2.6 RESEARCH ASSUMPTIONS 48
2.7 RESEARCH LIMITATIONS 49
2.8 RISK ASSESSMENT 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 54
4.1 MICROFLUIDICS MARKET OVERVIEW 54
4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER AND COUNTRY (2023) 55
?
4.3 MICROFLUIDICS MARKET, BY REGION 56
4.4 GEOGRAPHIC SNAPSHOT OF MICROFLUIDICS MARKET 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing requirement for point-of-care testing 58
5.2.1.2 Rising technological advancements 59
5.2.1.3 Increasing focus on data precision and accuracy 60
5.2.1.4 Economic benefits associated with microfluidics 60
5.2.1.5 Portability with microfluidic chip miniaturization 61
5.2.1.6 Rising demand for effective sample analysis 61
5.2.2 RESTRAINTS 62
5.2.2.1 Stringent regulatory approval process 62
5.2.2.2 Integration of microfluidics into current workflow 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Emergence of 3D cell culture systems 63
5.2.3.2 Growth potential of emerging economies 63
5.2.3.3 Use of microfluidics in life sciences & pharmaceutical industries 64
5.2.4 CHALLENGES 65
5.2.4.1 Low adoption of microfluidic devices among end users 65
5.3 INDUSTRY TRENDS 65
5.3.1 E-HEALTH DIAGNOSTICS 65
5.3.2 INTEGRATION OF MICROFLUIDICS WITH 3D PRINTING 66
5.3.3 R&D INVESTMENTS FOR PRODUCT DEVELOPMENT 66
5.4 PORTER'S FIVE FORCES ANALYSIS 69
5.4.1 THREAT OF NEW ENTRANTS 70
5.4.2 THREAT OF SUBSTITUTES 70
5.4.3 BARGAINING POWER OF SUPPLIERS 70
5.4.4 BARGAINING POWER OF BUYERS 70
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 71
5.5 KEY STAKEHOLDERS & BUYING CRITERIA 71
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 71
5.5.2 BUYING CRITERIA 72
5.6 REGULATORY LANDSCAPE 73
5.6.1 NORTH AMERICA 73
5.6.1.1 US 73
5.6.1.2 Canada 74
5.6.2 EUROPE 75
5.6.3 ASIA PACIFIC 77
5.6.3.1 Japan 77
5.6.3.2 China 78
5.6.3.3 India 78
5.6.4 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
5.7 REIMBURSEMENT SCENARIO 82
5.8 ECOSYSTEM ANALYSIS 83
5.9 VALUE CHAIN ANALYSIS 85
5.9.1 RESEARCH & DEVELOPMENT 85
5.9.2 RAW MATERIAL PROCUREMENT & MANUFACTURING 86
5.9.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES 86
5.10 SUPPLY CHAIN ANALYSIS 87
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 88
5.12 IMPACT OF GEN AI ON MICROFLUIDICS MARKET 89
5.13 PATENT ANALYSIS 89
5.13.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS 90
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 90
5.14 TRADE ANALYSIS 95
5.14.1 IMPORT DATA 95
5.14.2 EXPORT DATA 96
5.15 TECHNOLOGY ANALYSIS 96
5.15.1 KEY TECHNOLOGIES 97
5.15.1.1 Biosensor elements 97
5.15.1.2 Materials science 97
5.15.1.3 Microfabrication 98
5.15.1.4 Direct-writing 98
5.15.2 COMPLEMENTARY TECHNOLOGIES 99
5.15.2.1 MEMS 99
5.15.2.1.1 Green microfluidics 99
5.15.2.1.2 Microsensors/transducers 99
5.15.3 ADJACENT TECHNOLOGIES 100
5.15.3.1 3D inkjet printing 100
5.15.3.2 Lab-on-fiber 100
5.16 KEY CONFERENCES & EVENTS 101
5.17 PRICING ANALYSIS 102
5.17.1 AVERAGE SELLING PRICE TREND, BY REGION 102
5.17.2 AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER 105
5.18 UNMET NEEDS/END-USER EXPECTATIONS IN MICROFLUIDICS MARKET 105
5.19 CASE STUDY ANALYSIS 106
5.19.1 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD
VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ 106
5.19.2 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO 107
5.19.3 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY 107
5.20 INVESTMENT & FUNDING SCENARIO 108
6 MICROFLUIDICS MARKET, BY PRODUCT 110
6.1 INTRODUCTION 111
6.2 MICROFLUIDICS-BASED DEVICES 111
6.2.1 HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS
TO PROPEL MARKET 111
6.3 MICROFLUIDIC COMPONENTS 112
6.3.1 MICROFLUIDIC COMPONENTS, BY TYPE 113
6.3.1.1 Microfluidic chips 114
6.3.1.1.1 Chips to account for largest share of components market 114
6.3.1.2 Flow & pressure sensors 116
6.3.1.2.1 Utilization in lab diagnostics & research applications to drive market 116
6.3.1.3 Flow & pressure controllers 118
6.3.1.3.1 Cost-effectiveness and durability to boost demand 118
6.3.1.4 Microfluidic valves 119
6.3.1.4.1 Technological advancements to support market growth 119
6.3.1.5 Micropumps 123
6.3.1.5.1 Wide usage in drug delivery and glucose injections to fuel uptake 123
6.3.1.6 Microneedles 125
6.3.1.6.1 Miniscule size and painless patch application procedure to boost demand 125
6.3.1.7 Other microfluidic components 126
6.3.2 MICROFLUIDIC COMPONENTS, BY MATERIAL 127
6.3.2.1 Silicon 127
6.3.2.1.1 High precision and durability to boost demand 127
6.3.2.2 Polymers 128
6.3.2.2.1 Polymethyl Methacrylate (PMMA) 129
6.3.2.2.1.1 Durable alternative to glass to fuel uptake 129
6.3.2.2.2 Polydimethylsiloxane (PDMS) 130
6.3.2.2.2.1 Limited compatibility with specific solvents and acids to limit market adoption 130
6.3.2.2.3 Cyclic Olefin Copolymers 131
6.3.2.2.3.1 Low water absorption and enhanced electrical insulation properties to boost demand 131
6.3.2.2.4 Other polymers 132
6.3.2.3 Glass 133
6.3.2.3.1 High cost and brittleness to restrain market 133
?
7 MICROFLUIDICS MARKET, BY APPLICATION 134
7.1 INTRODUCTION 135
7.2 IVD 135
7.2.1 CLINICAL DIAGNOSTICS 137
7.2.1.1 Growing focus on early disease detection to drive market 137
7.2.2 POINT-OF-CARE TESTING (POCT) 138
7.2.2.1 High uptake of lab-on-a-chip technologies to fuel uptake 138
7.2.3 VETERINARY DIAGNOSTICS 139
7.2.3.1 Detection of toxins in food through LOC systems to support market growth 139
7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH 140
7.3.1 LAB ANALYTICS 141
7.3.1.1 Proteomic analysis 142
7.3.1.1.1 Utilization of lab-on-a-chip devices for therapeutic development to drive market 142
7.3.1.2 Genomic analysis 143
7.3.1.2.1 Growing focus on NGS and digital PCR to boost demand 143
7.3.1.3 Cell-based assays 144
7.3.1.3.1 Drug-screening for cross-reaction & toxicity testing to support market growth 144
7.3.1.4 Capillary electrophoresis 145
7.3.1.4.1 Growing applications for environmental monitoring and clinical diagnostics to fuel uptake 145
7.3.2 MICRODISPENSING 146
7.3.2.1 Suitability for low-viscosity applications to support market growth 146
7.3.3 MICROREACTORS 147
7.3.3.1 High uptake by leading companies for process optimization to fuel market 147
7.4 THERAPEUTICS 148
7.4.1 DRUG DELIVERY 149
7.4.1.1 Utilization of microneedles for painless and precise delivery to drive market 149
7.4.2 WEARABLE DEVICES 150
7.4.2.1 Integration of microfluidics-based wearable devices to support market growth 150
8 MICROFLUIDICS MARKET, BY END USER 152
8.1 INTRODUCTION 153
8.2 HOSPITALS AND DIAGNOSTIC CENTERS 153
8.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED EQUIPMENT AND FOCUS ON EARLY DISEASE DIAGNOSIS TO BOOST DEMAND 153
8.3 ACADEMIC & RESEARCH INSTITUTES 154
8.3.1 INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH 154
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 157
8.4.1 GROWING FOCUS ON BIOMARKER & DRUG DISCOVERY TO PROPEL MARKET 157
9 MICROFLUIDICS MARKET, BY REGION 159
9.1 INTRODUCTION 160
9.2 NORTH AMERICA 160
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 161
9.2.2 US 167
9.2.2.1 High healthcare expenditure and wide adoption of technologically advanced products to drive market 167
9.2.3 CANADA 169
9.2.3.1 Government funds and focus on research to support market growth 169
9.3 EUROPE 171
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 171
9.3.2 GERMANY 176
9.3.2.1 Growing focus on proteomics & genomics research to drive market 176
9.3.3 FRANCE 179
9.3.3.1 Favorable government support for R&D to drive market 179
9.3.4 UK 181
9.3.4.1 Rising cases of chronic diseases and increasing demand for POC testing to boost demand 181
9.3.5 ITALY 183
9.3.5.1 Innovative development of microfluidic chips to boost demand 183
9.3.6 SPAIN 185
9.3.6.1 Growth in pharmaceutical industry to fuel uptake 185
9.3.7 REST OF EUROPE 187
9.4 ASIA PACIFIC 189
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 190
9.4.2 CHINA 196
9.4.2.1 Growing focus on nanotechnology to drive market 196
9.4.3 JAPAN 198
9.4.3.1 High investments in academic research activities to propel market 198
9.4.4 INDIA 200
9.4.4.1 Increasing prevalence of CVD and diabetes to support market growth 200
9.4.5 AUSTRALIA 203
9.4.5.1 Rising incidence of infectious diseases to fuel uptake 203
9.4.6 SOUTH KOREA 205
9.4.6.1 Increasing R&D expenditure to drive growth 205
9.4.7 REST OF ASIA PACIFIC 208
?
9.5 LATIN AMERICA 209
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 209
9.5.2 BRAZIL 214
9.5.2.1 Increasing development of disease diagnostics kits to fuel uptake 214
9.5.3 MEXICO 216
9.5.3.1 Rising prevalence of chronic diseases to boost demand for POC testing 216
9.5.4 REST OF LATIN AMERICA 218
9.6 MIDDLE EAST & AFRICA 220
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 221
9.6.2 GCC COUNTRIES 225
9.6.2.1 Adoption of advanced microfluidic devices to support market growth 225
9.6.3 REST OF MIDDLE EAST & AFRICA 227
10 COMPETITIVE LANDSCAPE 230
10.1 INTRODUCTION 230
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 230
10.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET 230
10.4 REVENUE ANALYSIS 231
10.5 MARKET SHARE ANALYSIS BY KEY PLAYERS,2023 232
10.6 RANKING OF KEY MARKET PLAYERS 234
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 234
10.7.1 STARS 234
10.7.2 EMERGING LEADERS 234
10.7.3 PERVASIVE PLAYERS 235
10.7.4 PARTICIPANTS 235
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 236
10.7.5.1 Company footprint 236
10.7.5.2 Product footprint 237
10.7.5.3 Application footprint 238
10.7.5.4 End-user footprint 239
10.7.5.5 Region footprint 240
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 241
10.8.1 PROGRESSIVE COMPANIES 241
10.8.2 RESPONSIVE COMPANIES 241
10.8.3 DYNAMIC COMPANIES 241
10.8.4 STARTING BLOCKS 241
10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 243
10.8.5.1 Detailed list of key startup/SME players 243
10.8.5.2 Competitive benchmarking of key emerging players/startups 244
?
10.9 COMPANY VALUATION & FINANCIAL METRICS 245
10.9.1 FINANCIAL METRICS 245
10.9.2 COMPANY VALUATION 245
10.10 BRAND/PRODUCT COMPARATIVE ANALYSIS 246
10.11 COMPETITIVE SCENARIO 247
10.11.1 PRODUCT LAUNCHES & APPROVALS 247
10.11.2 DEALS 248
10.11.3 EXPANSIONS 249
10.11.4 OTHER DEVELOPMENTS 249
11 COMPANY PROFILES 250
11.1 KEY PLAYERS 250
11.1.1 DANAHER CORPORATION 250
11.1.1.1 Business overview 250
11.1.1.2 Products offered 252
11.1.1.3 Recent developments 253
11.1.1.3.1 Deals 253
11.1.1.3.2 Expansions 254
11.1.1.4 MnM view 254
11.1.1.4.1 Key strengths 254
11.1.1.4.2 Strategic choices 254
11.1.1.4.3 Weaknesses & competitive threats 254
11.1.2 ILLUMINA, INC. 255
11.1.2.1 Business overview 255
11.1.2.2 Products offered 257
11.1.2.3 Recent developments 258
11.1.2.3.1 Product launches & approvals 258
11.1.2.3.2 Deals 258
11.1.2.4 MnM view 260
11.1.2.4.1 Key strengths 260
11.1.2.4.2 Strategic choices 260
11.1.2.4.3 Weaknesses & competitive threats 260
11.1.3 BIOMERIEUX 261
11.1.3.1 Business overview 261
11.1.3.2 Products offered 263
11.1.3.3 Recent developments 263
11.1.3.3.1 Product launches & approvals 263
11.1.3.4 MnM view 264
11.1.3.4.1 Key strengths 264
11.1.3.4.2 Strategic choices 264
11.1.3.4.3 Weaknesses & competitive threats 264
?
11.1.4 THERMO FISHER SCIENTIFIC INC. 265
11.1.4.1 Business overview 265
11.1.4.2 Products offered 267
11.1.4.3 Recent developments 268
11.1.4.3.1 Product launches & approvals 268
11.1.4.3.2 Deals 270
11.1.4.3.3 Expansions 271
11.1.4.4 MnM view 271
11.1.4.4.1 Key strengths 271
11.1.4.4.2 Strategic choices 271
11.1.4.4.3 Weaknesses & competitive threats 271
11.1.5 ABBOTT LABORATORIES 272
11.1.5.1 Business overview 272
11.1.5.2 Products offered 274
11.1.5.3 MnM view 275
11.1.5.3.1 Key strengths 275
11.1.5.3.2 Strategic choices 275
11.1.5.3.3 Weaknesses & competitive threats 275
11.1.6 PARKER HANNIFIN CORP 276
11.1.6.1 Business overview 276
11.1.6.2 Products offered 278
11.1.7 SMC CORPORATION 281
11.1.7.1 Business overview 281
11.1.7.2 Products offered 282
11.1.7.3 Recent developments 285
11.1.7.3.1 Product launches 285
11.1.8 IDEX CORPORATION 287
11.1.8.1 Business overview 287
11.1.8.2 Products offered 288
11.1.8.3 Recent developments 290
11.1.8.3.1 Deals 290
11.1.9 FORTIVE 291
11.1.9.1 Business overview 291
11.1.9.2 Products offered 292
11.1.10 PERKINELMER INC. 295
11.1.10.1 Business overview 295
11.1.10.2 Products offered 297
11.1.10.3 Recent developments 298
11.1.10.3.1 Product launches 298
11.1.10.3.2 Deals 299
?
11.1.11 AGILENT TECHNOLOGIES, INC. 300
11.1.11.1 Business overview 300
11.1.11.2 Products offered 301
11.1.11.3 Recent developments 303
11.1.11.3.1 Product launches 303
11.1.11.3.2 Deals 304
11.1.11.3.3 Expansions 304
11.1.12 BIO-RAD LABORATORIES, INC. 305
11.1.12.1 Business overview 305
11.1.12.2 Products offered 307
11.1.12.3 Recent developments 308
11.1.12.3.1 Product launches 308
11.1.12.3.2 Deals 309
11.1.13 BECTON, DICKINSON AND COMPANY 310
11.1.13.1 Business overview 310
11.1.13.2 Products offered 312
11.1.13.3 Recent developments 314
11.1.13.3.1 Product launches & approvals 314
11.1.13.3.2 Deals 315
11.1.13.3.3 Expansions 316
11.1.14 F. HOFFMANN-LA ROCHE LTD. 317
11.1.14.1 Business overview 317
11.1.14.2 Products offered 318
11.1.14.3 Recent developments 319
11.1.14.3.1 Product launches & approvals 319
11.1.14.3.2 Deals 320
11.1.15 STANDARD BIOTOOLS 321
11.1.15.1 Business overview 321
11.1.15.2 Products offered 323
11.1.15.3 Recent developments 324
11.1.15.3.1 Product launches & approvals 324
11.1.15.3.2 Deals 325
11.1.16 QUIDELORTHO CORPORATION 326
11.1.16.1 Business overview 326
11.1.16.2 Products offered 328
11.1.16.3 Recent developments 329
11.1.16.3.1 Product approvals 329
11.1.16.3.2 Deals 330
11.1.16.3.3 Expansions 330
?
11.1.17 HOLOGIC, INC. 331
11.1.17.1 Business overview 331
11.1.17.2 Products offered 333
11.1.17.3 Recent developments 333
11.1.17.3.1 Product approvals 333
11.1.17.3.2 Deals 333
11.1.18 AIGNEP S.P.A. 334
11.1.18.1 Business overview 334
11.1.18.2 Products offered 335
11.1.18.3 Recent developments 335
11.1.18.3.1 Deals 335
11.1.19 DOLOMITE MICROFLUIDICS 336
11.1.19.1 Business overview 336
11.1.19.2 Products offered 337
11.1.19.3 Recent developments 341
11.1.19.3.1 Product launches & approvals 341
11.1.19.3.2 Deals 341
11.1.19.3.3 Other developments 341
11.1.20 ELVEFLOW 342
11.1.20.1 Business overview 342
11.1.20.2 Products offered 342
11.2 OTHER PLAYERS 344
11.2.1 NANOSTRING TECHNOLOGIES 344
11.2.2 NORTIS INC. 345
11.2.3 INNOVATIVE BIOCHIPS, LLC 346
11.2.4 FLUIDIC ANALYTICS 347
11.2.5 UFLUIDIX 348
11.2.6 HORIBA 349
11.2.7 MICRONIT B.V. 350
12 APPENDIX 351
12.1 DISCUSSION GUIDE 351
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 357
12.3 CUSTOMIZATION OPTIONS 359
12.4 RELATED REPORTS 359
12.5 AUTHOR DETAILS 360

TABLE 1 MICROFLUIDICS MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 MICROFLUIDICS MARKET: STUDY ASSUMPTIONS 48
TABLE 3 RISK ASSESSMENT: MICROFLUIDICS MARKET 49
TABLE 4 PRODUCT LAUNCHES BY KEY PLAYERS, 2023 59
TABLE 5 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET 67
TABLE 6 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES 69
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR MICROFLUIDICS MARKET 71
TABLE 8 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET, BY MATERIAL 72
TABLE 9 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED
DIAGNOSTIC DEVICES 73
TABLE 10 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 74
TABLE 11 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES 75
TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 77
TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 78
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 17 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 19 MAJOR CPT CODES FOR DIAGNOSTICS TESTS IN US, 2023 82
TABLE 20 MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM 84
TABLE 21 APPLICATIONS OF ARTIFICIAL INTELLIGENCE-POWERED MICROFLUIDICS 89
TABLE 22 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024 91
TABLE 23 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND) 95
TABLE 24 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019?2023 (USD THOUSAND) 96
TABLE 25 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023-2024) 101
TABLE 26 AVERAGE SELLING PRICE OF MICROFLUIDICS MEDICINE EQUIPMENT,
BY REGION, 2023 (USD THOUSAND) 104
TABLE 27 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD) 105
TABLE 28 MICROFLUIDICS MARKET: CURRENT UNMET NEEDS 105
TABLE 29 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ 106
TABLE 30 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO 107
TABLE 31 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY 107
?
TABLE 32 MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 111
TABLE 33 MICROFLUIDICS-BASED DEVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 112
TABLE 34 MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 113
TABLE 35 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 113
TABLE 36 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS 114
TABLE 37 MICROFLUIDIC CHIPS MARKET, BY REGION, 2022-2029 (USD MILLION) 116
TABLE 38 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS 117
TABLE 39 FLOW & PRESSURE SENSORS MARKET, BY REGION, 2022-2029 (USD MILLION) 117
TABLE 40 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS 118
TABLE 41 FLOW & PRESSURE CONTROLLERS MARKET, BY REGION,
2022-2029 (USD MILLION) 119
TABLE 42 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS 120
TABLE 43 MICROFLUIDIC VALVES MARKET, BY REGION, 2022-2029 (USD MILLION) 123
TABLE 44 MICROPUMPS OFFERED BY KEY PLAYERS 124
TABLE 45 MICROPUMPS MARKET, BY REGION, 2022-2029 (USD MILLION) 125
TABLE 46 MICRONEEDLES OFFERED BY KEY PLAYERS 126
TABLE 47 MICRONEEDLES MARKET, BY REGION, 2022-2029 (USD MILLION) 126
TABLE 48 OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION,
2022-2029 (USD MILLION) 126
TABLE 49 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 127
TABLE 50 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 128
TABLE 51 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 128
TABLE 52 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 129
TABLE 53 PMMA-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 129
TABLE 54 PDMS-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 130
TABLE 55 COC-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 131
TABLE 56 OTHER POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 132
TABLE 57 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET,
BY REGION, 2022-2029 (USD MILLION) 133
TABLE 58 MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 135
TABLE 59 MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 136
TABLE 60 MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY REGION, 2022-2029 (USD MILLION) 136
TABLE 61 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS,
BY REGION, 2022-2029 (USD MILLION) 137
TABLE 62 MICROFLUIDICS MARKET FOR POCT, BY REGION, 2022-2029 (USD MILLION) 138
TABLE 63 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS,
BY REGION, 2022-2029 (USD MILLION) 139
?
TABLE 64 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH,
BY TYPE, 2022-2029 (USD MILLION) 140
TABLE 65 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH,
BY REGION, 2022-2029 (USD MILLION) 141
TABLE 66 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2022-2029 (USD MILLION) 141
TABLE 67 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION,
2022-2029 (USD MILLION) 142
TABLE 68 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION,
2022-2029 (USD MILLION) 143
TABLE 69 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION,
2022-2029 (USD MILLION) 144
TABLE 70 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION,
2022-2029 (USD MILLION) 145
TABLE 71 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS,
BY REGION, 2022-2029 (USD MILLION) 146
TABLE 72 MICROFLUIDICS MARKET FOR MICRODISPENSING,
BY REGION, 2022-2029 (USD MILLION) 147
TABLE 73 MICROFLUIDICS MARKET FOR MICROREACTORS,
BY REGION, 2022-2029 (USD MILLION) 148
TABLE 74 MICROFLUIDICS MARKET FOR THERAPEUTICS,
BY TYPE, 2022-2029 (USD MILLION) 148
TABLE 75 MICROFLUIDICS MARKET FOR THERAPEUTICS,
BY REGION, 2022-2029 (USD MILLION) 149
TABLE 76 MICROFLUIDICS MARKET FOR DRUG DELIVERY,
BY REGION, 2022-2029 (USD MILLION) 150
TABLE 77 MICROFLUIDICS MARKET FOR WEARABLE DEVICES,
BY REGION, 2022-2029 (USD MILLION) 151
TABLE 78 MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION) 153
TABLE 79 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS,
BY REGION, 2022-2029 (USD MILLION) 154
TABLE 80 LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST 155
TABLE 81 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2022-2029 (USD MILLION) 156
TABLE 82 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 158
TABLE 83 MICROFLUIDICS MARKET, BY REGION, 2022-2029 (USD MILLION) 160
TABLE 84 NORTH AMERICA: MACROECONOMIC OUTLOOK 161
TABLE 85 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 163
TABLE 86 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 163
TABLE 87 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 88 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 164
TABLE 89 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 164
?
TABLE 90 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL
& LIFE SCIENCE RESEARCH, BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 91 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 165
TABLE 92 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS,
BY TYPE, 2022-2029 (USD MILLION) 165
TABLE 93 NORTH AMERICA: MICROFLUIDICS COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 165
TABLE 94 NORTH AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 166
TABLE 95 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER,
2022-2029 (USD MILLION) 166
TABLE 96 US: KEY MACROINDICATORS 167
TABLE 97 US: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 167
TABLE 98 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 99 US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022-2029 (USD MILLION) 168
TABLE 100 US: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 101 CANADA: KEY MACROINDICATORS 169
TABLE 102 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 170
TABLE 103 CANADA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 170
TABLE 104 CANADA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 170
TABLE 105 CANADA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 171
TABLE 106 EUROPE: MACROECONOMIC OUTLOOK 172
TABLE 107 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 108 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 173
TABLE 109 EUROPE: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 110 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 173
TABLE 111 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 112 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 113 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 114 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 175
TABLE 115 EUROPE: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 175
TABLE 116 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 175
TABLE 117 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION) 176
TABLE 118 GERMANY: KEY MACROINDICATORS 177
TABLE 119 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 177
TABLE 120 GERMANY: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 121 GERMANY: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 178
TABLE 122 GERMANY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 123 FRANCE: KEY MACROINDICATORS 179
TABLE 124 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 179
TABLE 125 FRANCE: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 180
TABLE 126 FRANCE: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 180
TABLE 127 FRANCE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 128 UK: KEY MACROINDICATORS 181
TABLE 129 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 182
TABLE 130 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 131 UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL,
2022-2029 (USD MILLION) 182
TABLE 132 UK: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 133 ITALY: KEY MACROINDICATORS 183
TABLE 134 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 184
TABLE 135 ITALY: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 136 ITALY: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 184
TABLE 137 ITALY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 138 SPAIN: KEY MACROINDICATORS 186
TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 186
TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 141 SPAIN: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 187
TABLE 142 SPAIN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 143 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 188
TABLE 144 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 145 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 188
TABLE 146 REST OF EUROPE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 147 ASIA PACIFIC: MACROECONOMIC INDICATORS 190
TABLE 148 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 192
TABLE 149 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 192
TABLE 150 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 151 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 193
TABLE 152 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL &
LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 154 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 155 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 156 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 195
TABLE 157 ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER,
2022-2029 (USD MILLION) 196
TABLE 159 CHINA: KEY MACROINDICATORS 196
TABLE 160 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 197
TABLE 161 CHINA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 162 CHINA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 197
TABLE 163 CHINA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 164 JAPAN: KEY MACROINDICATORS 199
TABLE 165 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 199
TABLE 166 JAPAN: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 167 JAPAN: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 200
TABLE 168 JAPAN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 200
TABLE 169 INDIA: KEY MACROINDICATORS 201
TABLE 170 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 201
TABLE 171 INDIA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 172 INDIA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 202
TABLE 173 INDIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 174 AUSTRALIA: KEY MACROINDICATORS 204
TABLE 175 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 204
TABLE 176 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 177 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 205
TABLE 178 AUSTRALIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 179 SOUTH KOREA: KEY MACROINDICATORS 206
TABLE 180 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 206
TABLE 181 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 182 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 207
TABLE 183 SOUTH KOREA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 184 REST OF ASIA PACIFIC: MICROFLUIDICS MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 208
TABLE 185 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 186 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 209
TABLE 187 REST OF ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 188 LATIN AMERICA: MACROECONOMIC OUTLOOK 210
TABLE 189 LATIN AMERICA: MICROFLUIDICS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 210
TABLE 190 LATIN AMERICA: MICROFLUIDICS MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 210
TABLE 191 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 192 LATIN AMERICA: MICROFLUIDICS MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 211
TABLE 193 LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 194 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL &
LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 195 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 196 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 197 LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 198 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 213
TABLE 199 LATIN AMERICA: MICROFLUIDICS MARKET,
BY END USER, 2022-2029 (USD MILLION) 214
TABLE 200 BRAZIL: KEY MACROINDICATORS 214
TABLE 201 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 215
TABLE 202 BRAZIL: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 203 BRAZIL: MICROFLUIDICS COMPONENT MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 215
TABLE 204 BRAZIL: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 216
?
TABLE 205 MEXICO: KEY MACROINDICATORS 216
TABLE 206 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 217
TABLE 207 MEXICO: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 208 MEXICO: MICROFLUIDICS MARKET, MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 217
TABLE 209 MEXICO: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 210 REST OF LATIN AMERICA: MICROFLUIDICS MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 218
TABLE 211 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 212 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 219
TABLE 213 REST OF LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 220
TABLE 214 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET,
BY REGION, 2022-2029 (USD MILLION) 221
TABLE 215 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 221
TABLE 216 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 222
TABLE 217 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 218 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 223
TABLE 219 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 220 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL &
LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 221 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 222 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 223 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 224
TABLE 224 MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 225 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET,
BY END USER, 2022-2029 (USD MILLION) 225
TABLE 226 GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 226
TABLE 227 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 228 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 227
TABLE 229 GCC COUNTRIES: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 230 REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 228
TABLE 231 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 232 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET,
BY MATERIAL, 2022-2029 (USD MILLION) 229
TABLE 233 REST OF MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 234 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 230
TABLE 235 MICROFLUIDICS MARKET: DEGREE OF COMPETITION 233
TABLE 236 MICROFLUIDICS MARKET: PRODUCT FOOTPRINT 237
TABLE 237 MICROFLUIDICS MARKET: APPLICATION FOOTPRINT 238
TABLE 238 MICROFLUIDICS MARKET: END-USER FOOTPRINT 239
TABLE 239 MICROFLUIDICS MARKET: REGION FOOTPRINT 240
TABLE 240 MICROFLUIDICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 243
TABLE 241 MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 244
TABLE 242 MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021?AUGUST 2024 247
TABLE 243 MICROFLUIDICS MARKET: DEALS, JANUARY 2021-AUGUST 2024 248
TABLE 244 MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024 249
TABLE 245 MICROFLUIDICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021?AUGUST 2024 249
TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW 250
TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED 252
TABLE 248 DANAHER CORPORATION: DEALS, JANUARY 2021?AUGUST 2024 253
TABLE 249 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021?AUGUST 2024 254
TABLE 250 ILLUMINA, INC.: COMPANY OVERVIEW 255
TABLE 251 ILLUMINA INC.: PRODUCTS OFFERED 257
TABLE 252 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021?AUGUST 2024 258
TABLE 253 ILLUMINA, INC.: DEALS, JANUARY 2021?AUGUST 2024 258
TABLE 254 BIOMERIEUX: COMPANY OVERVIEW 261
TABLE 255 BIOMERIEUX: PRODUCTS OFFERED 263
TABLE 256 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024 263
TABLE 257 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 265
TABLE 258 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 267
TABLE 259 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021?AUGUST 2024 268
TABLE 260 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024 270
TABLE 261 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024 271
TABLE 262 ABBOTT LABORATORIES: COMPANY OVERVIEW 272
TABLE 263 ABBOTT LABORATORIES: PRODUCTS OFFERED 274
TABLE 264 PARKER HANNIFIN CORP: COMPANY OVERVIEW 276
TABLE 265 PARK HANNIFIN CORP: PRODUCTS OFFERED 278
TABLE 266 SMC CORPORATION: COMPANY OVERVIEW 281
TABLE 267 SMC CORPORATION: PRODUCTS OFFERED 282
TABLE 268 SMC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024 285
?
TABLE 269 IDEX CORPORATION: COMPANY OVERVIEW 287
TABLE 270 IDEX CORPORATION: PRODUCTS OFFERED 288
TABLE 271 IDEX CORPORATION: DEALS, JANUARY 2021-AUGUST 2024 290
TABLE 272 FORTIVE: COMPANY OVERVIEW 291
TABLE 273 FORTIVE: PRODUCTS OFFERED 292
TABLE 274 PERKINELMER INC.: COMPANY OVERVIEW 295
TABLE 275 PERKINELMER INC.: PRODUCTS OFFERED 297
TABLE 276 PERKINELMER INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024 298
TABLE 277 PERKINELMER INC.: DEALS, JANUARY 2021-AUGUST 2024 299
TABLE 278 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 300
TABLE 279 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 301
TABLE 280 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,
JANUARY 2021-AUGUST 2024 303
TABLE 281 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-AUGUST 2024 304
TABLE 282 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024 304
TABLE 283 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 305
TABLE 284 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 307
TABLE 285 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES,
JANUARY 2021-AUGUST 2024 308
TABLE 286 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-AUGUST 2024 309
TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 310
TABLE 288 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 312
TABLE 289 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024 314
TABLE 290 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-AUGUST 2024 315
TABLE 291 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021-AUGUST 2024 316
TABLE 292 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 317
TABLE 293 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 318
TABLE 294 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-AUGUST 2024 319
TABLE 295 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2021-AUGUST 2024 320
TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW 321
TABLE 297 STANDARD BIOTOOLS: PRODUCTS OFFERED 323
TABLE 298 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-AUGUST 2024 324
TABLE 299 STANDARD BIOTOOLS: DEALS, JANUARY 2021-AUGUST 2024 325
TABLE 300 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 326
TABLE 301 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 328
TABLE 302 QUIDELORTHO CORPORATION: PRODUCT APPROVALS,
JANUARY 2021-AUGUST 2024 329
TABLE 303 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-AUGUST 2024 330
TABLE 304 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024 330
?
TABLE 305 HOLOGIC, INC.: COMPANY OVERVIEW 331
TABLE 306 HOLOGIC, INC.: PRODUCTS OFFERED 333
TABLE 307 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024 333
TABLE 308 HOLOGIC, INC: DEALS, JANUARY 2021-AUGUST 2024 333
TABLE 309 AIGNEP S.P.A.: COMPANY OVERVIEW 334
TABLE 310 AIGNEP S.P.A.: PRODUCTS OFFERED 335
TABLE 311 AIGNEP S.P.A.: DEALS, JANUARY 2021-AUGUST 2024 335
TABLE 312 DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW 336
TABLE 313 DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED 337
TABLE 314 DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-AUGUST 2024 341
TABLE 315 DOLOMITE MICROFLUIDICS: DEALS, JANUARY 2021-AUGUST 2024 341
TABLE 316 DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS,
JANUARY 2021?AUGUST 2024 341
TABLE 317 ELVEFLOW: COMPANY OVERVIEW 342
TABLE 318 ELVEFLOW: PRODUCTS OFFERED 342
TABLE 319 NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW 344
TABLE 320 NORTIS INC.: COMPANY OVERVIEW 345
TABLE 321 INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW 346
TABLE 322 FLUIDIC ANALYTICS: COMPANY OVERVIEW 347
TABLE 323 UFLUIDIX: COMPANY OVERVIEW 348
TABLE 324 HORIBA: COMPANY OVERVIEW 349
TABLE 325 MICRONIT B.V.: COMPANY OVERVIEW 350

FIGURE 1 MICROFLUIDICS MARKET SEGMENTATION 31
FIGURE 2 MICROFLUIDICS MARKET: RESEARCH DESIGN 36
FIGURE 3 PRIMARY SOURCES 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 41
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42
FIGURE 7 MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1
(COMPANY REVENUE ESTIMATION) 43
FIGURE 8 MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 44
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46
FIGURE 10 TOP-DOWN APPROACH 46
FIGURE 11 DATA TRIANGULATION 47
FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 50
FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 51
FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 52
FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 52
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MICROFLUIDICS MARKET, 2024-2029 53
FIGURE 17 GROWING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE MARKET 54
FIGURE 18 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE FOR JAPAN IN 2023 55
FIGURE 19 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET IN 2024 56
FIGURE 20 CHINA TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD 56
FIGURE 21 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 57
FIGURE 22 GLOBAL CANCER INCIDENCE, 2020?2040 58
FIGURE 23 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES ANALYSIS 69
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET, BY MATERIAL 71
FIGURE 25 KEY BUYING CRITERIA, BY MATERIAL 72
FIGURE 26 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY 74
FIGURE 27 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA 75
FIGURE 28 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 76
FIGURE 29 INDIA: REGULATORY PROCESS FOR IVD DEVICES 79
FIGURE 30 MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS 83
FIGURE 31 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS 86
FIGURE 32 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS 88
FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS 88
FIGURE 34 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2014-AUGUST 2024) 90
FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2021- 2023 (USD) 103
FIGURE 36 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER 105
FIGURE 37 INVESTMENT & FUNDING SCENARIO, 2019?2023 108
FIGURE 38 NUMBER OF INVESTOR DEALS, BY KEY PLAYERS, 2019-2023 109
FIGURE 39 VALUE OF INVESTOR DEALS BY KEY PLAYERS, 2019-2023 (USD MILLION) 109
FIGURE 40 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 162
FIGURE 41 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 191
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2019?2023) 232
FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2023) 232
FIGURE 44 RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2023 234
FIGURE 45 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 235
FIGURE 46 MICROFLUIDICS MARKET: COMPANY FOOTPRINT 236
FIGURE 47 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 242
FIGURE 48 EV/EBITDA OF KEY VENDORS 245
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 245
FIGURE 50 MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 246
FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 251
FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2023) 256
FIGURE 53 BIOMERIEUX: COMPANY SNAPSHOT (2023) 262
FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 266
FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 273
FIGURE 56 PARKER HANNIFIN CORP: COMPANY SNAPSHOT (2023) 277
FIGURE 57 SMC CORPORATION: COMPANY SNAPSHOT (2023) 281
FIGURE 58 IDEX CORPORATION: COMPANY SNAPSHOT (2023) 288
FIGURE 59 FORTIVE: COMPANY SNAPSHOT (2023) 292
FIGURE 60 PERKINELMER INC.: COMPANY SNAPSHOT (2023) 296
FIGURE 61 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 301
FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 306
FIGURE 63 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 311
FIGURE 64 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 318
FIGURE 65 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023) 322
FIGURE 66 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023) 327
FIGURE 67 HOLOGIC, INC.: COMPANY SNAPSHOT (2023) 332